Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% |
|
-.--% | -.--% |
2015 | PharmaRoth Labs, Inc. Receives Additional Order from Marcas de Renombre | CI |
2014 | PharmaRoth Labs, Inc. Announces New Distribution Agreement with Biotechnology Co., Ltd | CI |
Business Summary
Number of employees: 2
Sales per Business
USD in Million | 2016 | Weight | 2017 | Weight | Delta |
---|---|---|---|---|---|
Nutraceutical Drugs
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -31.08% |
Sales per region
USD in Million | 2016 | Weight | 2017 | Weight | Delta |
---|---|---|---|---|---|
Americas
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -31.08% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 10-08-30 | |
Barry W. Hall
DFI | Director of Finance/CFO | 76 | 13-01-21 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 10-08-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 394,014,970 | 121,850,000 ( 30.93 %) | 0 | 30.93 % |
Company contact information
PharmaRoth Labs, Inc.
10325 Falls Church Avenue
89144, Las Vegas
+212-541-6222
http://www.pharmaroth.com![address PharmaRoth Labs, Inc.(ROTH)](https://cdn.zonebourse.com/static/address/120792381.png)
Sector
1st Jan change | Capi. | |
---|---|---|
-.--% | 390 | |
+55.95% | 811B | |
+43.62% | 640B | |
-6.98% | 353B | |
+19.08% | 333B | |
+9.05% | 302B | |
+16.30% | 246B | |
+2.41% | 225B | |
+12.47% | 218B | |
+8.91% | 168B |
- Stock Market
- Equities
- ROTH Stock
- Company PharmaRoth Labs, Inc.